Degradation of methoxysuccinyl-phe-leu-phe-7-amido-4-trifluoromethyl coumarin (FLF) in cultured myotubes and HepG2 cells is proteasome- and calpain/calcium-dependent

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 6, 2000, Pages 677-686

  Li, Bing Guo ^a   Fang, Cheng Hui ^a   Hasselgren, Per Olof ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Calpain; Hepatocytes; Myotubes; Proteasome; Proteolysis

Indexed keywords

CALCIUM; CALPAIN; COUMARIN DERIVATIVE; INSULIN; PROTEASOME; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; HUMAN; HUMAN CELL; LIVER CELL; LYSOSOME; MALE; MYOTUBE; NONHUMAN; PROTEIN DEGRADATION; RAT;

ANIMALS; CALCIUM; CALPAIN; CELL LINE; COUMARINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INSULIN; LACTONES; LYSOSOMES; MALE; MULTIENZYME COMPLEXES; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0002903773     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00010-8     Document Type: Article

References (25)

1. Hasselgren P.O., Fischer J.E. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann. Surg. 225:1997;307-316.
2. 2+-dependent systems. Adv. Molec. Cell Biol. 27:1998;235-266.
3. Tiao G., Fagan J.M., Samuels N., James J.H., Hudson K., Lieberman M., Fischer J.E., Hasselgren P.O. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94:1994;2255-2264.
4. Tiao G., Hobler S., Wang J.J., Meyer T.A., Luchette F.A., Fischer J.E., Hasselgren P.O. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J. Clin. Invest. 99:1997;163-168.
5. Fang C.H., Tiao G., James J.H., Ogle C., Fischer J.E., Hasselgren P.O. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J. Am. Coll. Surg. 180:1995;161-170.
6. Fang C.H., Wang J.J., Hobler S., Li B.G., Fischer J.E., Hasselgren P.O. Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats. Clin. Sci. 95:1998;225-233.
7. Medina R., Wing S.S., Haas A., Goldberg A.L. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed. Biochim. Acta. 50:1991;347-356.
8. Baracos V.E., DeVivo C., Hoyle D.H.R., Goldberg A.L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268:1995;E996-E1006.
9. A. Williams, X. Sun, J.E. Fischer, P.O. Hasselgren, The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer, Surgery 126 (1999) 744-750.
10. Mitch W.E., Medina R., Grieber S., May R.C., England B.K., Price S.R., Bailey J.L., Goldberg A.L. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine-triphosphate-dependent pathway including ubiquitin and proteasomes. J. Clin. Invest. 93:1994;2127-2133.
11. 2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc. Natl. Acad. Sci. USA. 93:1996;2714-2718.
12. Llovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F.J., Authier F.J., Gherardi R.K., Argiles J.M. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. Int. J. Molec. Med. 2:1998;69-73.
13. Craiu A., Gaczynska M., Akopian T., Gramm C.F., Fenteany G., Goldberg A.L., Rock K.L. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatiblity complex class I antigen presentation. J. Biol. Chem. 272:1997;13437-13445.
14. Hamel F.G., Bennett R.G., Harmon K.S., Duckworth W.C. Insulin inhibition of proteasome activity in intact cells. Biochem. Biophys. Res. Commun. 234:1997;671-674.
15. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:1998;397-403.
16. Wang L., Luo G.J., Wang J.J., Hasselgren P.O. Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock. 10:1998;298-306.
17. Dick L.R., Cruikshank A.A., Grenier L., Melandri F.D., Nunes S.L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clastolactacystin β-lactone. J. Biol. Chem. 271:1996;7273-7276.
18. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey J., Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
19. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Huang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
20. Seglen P.O., Grinde B., Solheim A.E. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur. J. Biochem. 95:1979;215-225.
21. Solheim A.E., Seglen P.O. Structural and physical changes in lysosomes from isolated rate hepatocytes treated with methylamine. Biochim. Biophys. Acta. 763:1983;284-291.
22. Tapper H., Sundler R. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem. J. 272:1990;407-414.
23. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem. J. 328:1997;721-732.
24. Mantle D., Hardy M.F., Lauffart B., McDermott J.R., Smith A.I., Pennington R.J.T. Purification and characterization of the major aminopeptidase from human skeletal muscle. Biochem. J. 211:1983;567-573.
25. Mortimore G.E., Poso A.R., Lardeux B.R. Mechanism and regulation of protein degradation in liver. Diab. Metab. Rev. 5:1989;49-70.